Interestingly enough, Moderna stopped trials on an Epstein-Barr mRNA shot due to…
Ready for it?..
Myocarditis.
After ONE participant developed myocarditis. ONE.
The case “necessitates an immediate suspension of all dosing for ALL adolescents,” an investigator at the company that is supervising the trial for Moderna wrote, adding, “Please confirm understanding and receipt of this urgent communication.”
The trial subjects should continue to be monitored for safety, the investigator wrote. About 150 adolescents are in the trial, along with 272 people aged 18-30.
So it seems like the spike protein in covid may not be the culprit. Looks like the mRNA carrier is most likely the issue.
Leave a Reply